Work

ヒト尿路上皮癌における B7-H1 の発現は WHO grade および術後予後と有意に関係する

Year: 2007
Type: dissertation
Study design: Observational Study
Abstract: The programmed death-1 (PD-1)/B7-H1 (also called PD-L1) pathway negatively regulates T-cell activation and has been suggested to play an important role in regulating antitumor host immunity. To investigate the clinical significance of B7-H1 expression to the tumor grade and postoperative prognosis of patients with urothelial cancer, we analyzed the relationship between B7-H1 expression and various clinicopathological features and postoperative prognosis. B7-H1 expression in tumors and the numbers and phenotypes of tumor-infiltrating lymphocytes were evaluated by immunohistochemistry and flow cytometry. A substantial expression of B7-H1 was observed in all urothelial cancers investigated. Tumor specimens from patients with higher WHO grade or primary tumor classifications showed significantly higher percentages of tumor-associated B7-H1. Tumor-associated B7-H1 expression was significantly associated with a high frequency of postoperative recurrence and poor survival rate. Furthermore, multivariate analysis indicated that tumor-associated B7-H1 was more significant prognostic factor than WHO grade. In conclusion, our results demonstrate that the aberrant expression of B7-H1 in urothelial cancer is associated with aggressive tumors, suggesting a regulatory role of tumor-associated B7-H1 in antitumor immunity.
Institution: Kumamoto University
Language: Japanese
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7146464521
Cites:
Cited by:
Related to: 9